Free tool
Healthcare stocks
We cover 994 companies in the Healthcare sector. The median market value in the group is $37.62M. Across the group, the median move over the past trading day is −0.04%. 40% of the 969 with a 200-day average trade above it. Price change over the past year runs from −79.2% to +80.8% across the middle 80 percent of the group, with a median of −17.9%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
994 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LILY34.SA | Eli Lilly and Company | $1.10T | Mega cap | +59.83% |
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% |
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% |
| JNJB34.SA | Johnson & Johnson | $658.09B | Mega cap | +47.82% |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% |
| ABBV34.SA | AbbVie Inc. | $467.00B | Mega cap | +21.88% |
| RHO.DE | Roche Holding AG | $370.84B | Mega cap | +41.42% |
| N1VS34.SA | Novartis AG | $301.83B | Mega cap | +20.04% |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +28.89% |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% |
| A1ZN34.SA | AstraZeneca PLC | $258.63B | Mega cap | +0.13% |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +6.22% |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% |
| NVO.WA | Novo Nordisk A/S | $212.23B | Mega cap | −9.22% |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% |
| N1VO34.SA | Novo Nordisk A/S | $208.90B | Mega cap | −17.86% |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% |
| PODD | Insulet Corporation | $9.94B | Mid cap | −57.12% |
| AVTR | Avantor, Inc. | $9.81B | Mid cap | +9.93% |
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +83.55% |
| TWST | Twist Bioscience Corporation | $9.41B | Mid cap | +451.89% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| WDH1.DE | Demant A/S | $9.33B | Mid cap | −5.53% |
| KRK.WA | Krka, d. d. | $9.20B | Mid cap | +30.59% |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +99.97% |
| IMVT | Immunovant, Inc. | $9.07B | Mid cap | +189.13% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −9.65% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% |
| BRKR | Bruker Corporation | $8.69B | Mid cap | +70.56% |
| ATR | AptarGroup, Inc. | $8.60B | Mid cap | −1.89% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +4.01% |
| 4523.T | Eisai Co., Ltd. | $8.48B | Mid cap | +7.64% |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.42B | Mid cap | +92.61% |
| ALKS | Alkermes plc | $8.25B | Mid cap | +68.07% |
| SYRE | Spyre Therapeutics, Inc. | $8.13B | Mid cap | +446.12% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% |
| 2413.T | M3, Inc. | $7.53B | Mid cap | −17.22% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +54.43% |
| SRRK | Scholar Rock Holding Corporation | $7.31B | Mid cap | +74.18% |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% |
| ALK-B.CO | ALK-Abelló A/S | $7.26B | Mid cap | +5.09% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +56.66% |
| SHL.AX | Sonic Healthcare Limited | $7.14B | Mid cap | −11.84% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% |
| PACS | PACS Group, Inc. | $7.03B | Mid cap | +274.28% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| CGON | CG Oncology, Inc. | $6.95B | Mid cap | +196.15% |
| 3391.T | Tsuruha Holdings Inc. | $6.89B | Mid cap | +5.97% |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | $6.82B | Mid cap | +15.35% |
| ERAS | Erasca, Inc. | $6.70B | Mid cap | +1112.03% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +53.99% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% |
| RADL3.SA | Raia Drogasil S.A. | $6.56B | Mid cap | +7.42% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% |
| 3088.T | MatsukiyoCocokara & Co. | $6.45B | Mid cap | −14.74% |
| COH.AX | Cochlear Limited | $6.39B | Mid cap | −53.79% |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +196.85% |
| BLTE | Belite Bio, Inc | $6.31B | Mid cap | +144.07% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +154.86% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.27B | Mid cap | +92.20% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% |
| BLCO.TO | Bausch + Lomb Corporation | $6.18B | Mid cap | +19.34% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.56% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +356.93% |
| STVN | Stevanato Group S.p.A. | $6.11B | Mid cap | −0.09% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $6.07B | Mid cap | +46.02% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.05B | Mid cap | +133.47% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% |
| CTEC.L | Convatec Group PLC | $6.01B | Mid cap | −1.95% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% |
| DFTX | Definium Therapeutics, Inc. | $5.88B | Mid cap | +344.37% |
| TFX | Teleflex Incorporated | $5.88B | Mid cap | +8.06% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% |
| SHC | Sotera Health Company | $5.58B | Mid cap | +18.42% |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +5.41% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | −0.28% |
| GRFS | Grifols, S.A. | $5.38B | Mid cap | −19.39% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.07B | Mid cap | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +93.26% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | $4.89B | Mid cap | −11.24% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +207.13% |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +121.31% |
| CELC | Celcuity Inc. | $4.65B | Mid cap | +90.31% |
| WAY | Waystar Holding Corp. | $4.63B | Mid cap | −34.97% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.63B | Mid cap | +66.34% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.61B | Mid cap | −9.62% |
| BLLN | BillionToOne, Inc. | $4.54B | Mid cap | −11.68% |
| 000100.KS | Yuhan Corporation | $4.50B | Mid cap | −27.54% |
| ICUI | ICU Medical, Inc. | $4.49B | Mid cap | +41.83% |
| NVST | Envista Holdings Corporation | $4.47B | Mid cap | +30.89% |
| ELVN | Enliven Therapeutics, Inc. | $4.46B | Mid cap | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +50.93% |
| DOCS | Doximity, Inc. | $4.41B | Mid cap | −63.61% |
| LIVN | LivaNova PLC | $4.41B | Mid cap | +41.56% |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% |
| MANE | Veradermics, Incorporated | $4.29B | Mid cap | +172.32% |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.23B | Mid cap | +47.06% |
| ADPT | Adaptive Biotechnologies Corporation | $4.18B | Mid cap | +101.70% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| IRTC | iRhythm Holdings, Inc. | $4.06B | Mid cap | −29.83% |
| 4506.T | Sumitomo Pharma Co., Ltd. | $4.05B | Mid cap | −3.59% |
| LEGN | Legend Biotech Corporation | $4.02B | Mid cap | −40.44% |
| VKTX | Viking Therapeutics, Inc. | $4.01B | Mid cap | +29.15% |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +57.50% |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% |
| 000105.KS | Yuhan Corporation | $3.84B | Mid cap | −32.04% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.82B | Mid cap | +4.88% |
| CAMX.ST | Camurus AB (publ) | $3.79B | Mid cap | −15.35% |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −27.31% |
| TLX | Telix Pharmaceuticals Limited | $3.77B | Mid cap | −8.02% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.74B | Mid cap | +21.45% |
| 7459.T | MediPal Holdings Corporation | $3.72B | Mid cap | +13.38% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% |
| OPCH | Option Care Health, Inc. | $3.60B | Mid cap | −15.91% |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +159.74% |
| GRAL | GRAIL, Inc. | $3.55B | Mid cap | +136.66% |
| QURE | uniQure N.V. | $3.53B | Mid cap | +223.49% |
| NHC | National HealthCare Corporation | $3.53B | Mid cap | +103.83% |
| 22Z.DE | Zealand Pharma A/S | $3.37B | Mid cap | −28.16% |
| ZEAL.CO | Zealand Pharma A/S | $3.34B | Mid cap | −25.94% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +188.94% |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +11.97% |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.26B | Mid cap | −26.59% |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | −2.08% |
| MBX | MBX Biosciences, Inc. | $3.22B | Mid cap | +366.53% |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +79.06% |
| AFX.DE | Carl Zeiss Meditec AG | $3.19B | Mid cap | −24.83% |
| TMDX | TransMedics Group, Inc. | $3.19B | Mid cap | −21.43% |
| CLDX | Celldex Therapeutics, Inc. | $3.19B | Mid cap | +79.51% |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% |
| WRBY | Warby Parker Inc. | $3.15B | Mid cap | −3.96% |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.13B | Mid cap | −28.60% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +60.64% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.10B | Mid cap | +22.19% |
| ALMS | Alumis Inc. | $3.06B | Mid cap | +380.08% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −24.65% |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.69% |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +55.61% |
| ALHC | Alignment Healthcare, Inc. | $2.88B | Mid cap | −13.88% |
| ACHC | Acadia Healthcare Company, Inc. | $2.85B | Mid cap | +37.81% |
| B72.DE | AtaiBeckley Inc. | $2.79B | Mid cap | +59.69% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.77B | Mid cap | +615.10% |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% |
| 9989.T | Sundrug Co.,Ltd. | $2.76B | Mid cap | −17.34% |
| VRDN | Viridian Therapeutics, Inc. | $2.75B | Mid cap | +30.71% |
| RGC | Regencell Bioscience Holdings Limited | $2.72B | Mid cap | −61.38% |
| WGS | GeneDx Holdings Corp. | $2.69B | Mid cap | −30.11% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +219.58% |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +67.21% |
| PGEN | Precigen, Inc. | $2.65B | Mid cap | +61.66% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.61B | Mid cap | −0.42% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −12.10% |
| EBO.AX | EBOS Group Limited | $2.60B | Mid cap | −37.83% |
| PHVS | Pharvaris N.V. | $2.60B | Mid cap | +55.59% |
| BHVN | Biohaven Ltd. | $2.56B | Mid cap | +8.65% |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% |
| EMEIS.PA | emeis Société anonyme | $2.55B | Mid cap | +10.93% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% |
| 2784.T | Alfresa Holdings Corporation | $2.53B | Mid cap | +6.80% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +151.95% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +15.38% |
| CURA.TO | Curaleaf Holdings, Inc. | $2.51B | Mid cap | +197.74% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% |
| PBH | Prestige Consumer Healthcare Inc. | $2.47B | Mid cap | −22.12% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| NUVB | Nuvation Bio Inc. | $2.44B | Mid cap | +135.93% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.44B | Mid cap | +5.23% |
| BHC | Bausch Health Companies Inc. | $2.43B | Mid cap | −10.45% |
| BHC.TO | Bausch Health Companies Inc. | $2.43B | Mid cap | −9.88% |
| KLRA | Kailera Therapeutics, Inc. | $2.39B | Mid cap | −29.08% |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% |
| ALMR | Alamar Biosciences, Inc. | $2.36B | Mid cap | +54.91% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +45.50% |
| 009420.KS | Hanall Biopharma Co., Ltd. | $2.36B | Mid cap | +112.62% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +41.94% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| BFLY | Butterfly Network, Inc. | $2.30B | Mid cap | +450.32% |
| COAG | Hemab Therapeutics Holdings, Inc. | $2.30B | Mid cap | +44.68% |
| MLYS | Mineralys Therapeutics, Inc. | $2.28B | Mid cap | +70.22% |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% |
| CLOV | Clover Health Investments, Corp. | $2.26B | Mid cap | +57.99% |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | +1.03% |
| ADUS | Addus HomeCare Corporation | $2.25B | Mid cap | +4.50% |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +4.47% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +56.87% |
| 302440.KS | SK bioscience Co.,Ltd. | $2.18B | Mid cap | −20.29% |
| XRAY | DENTSPLY SIRONA Inc. | $2.18B | Mid cap | −21.61% |
| EXE.TO | Extendicare Inc. | $2.18B | Mid cap | +146.56% |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% |
| 9987.T | Suzuken Co., Ltd. | $2.17B | Mid cap | −12.93% |
| HCM.L | HUTCHMED (China) Limited | $2.16B | Mid cap | −18.08% |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% |
| ZBIO | Zenas BioPharma, Inc. | $2.15B | Mid cap | +97.73% |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +70.71% |
| CLOV34.SA | Clover Health Investments, Corp. | $2.15B | Mid cap | +45.23% |
| HCM | HUTCHMED (China) Limited | $2.15B | Mid cap | −17.45% |
| STOK | Stoke Therapeutics, Inc. | $2.14B | Mid cap | +71.45% |
| GN.CO | GN Store Nord A/S | $2.13B | Mid cap | −18.50% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.11B | Mid cap | +2.80% |
| NVCR | NovoCure Limited | $2.08B | Mid cap | +50.21% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% |
| GENB | Generate Biomedicines, Inc. | $2.07B | Mid cap | +27.59% |
| SRPT | Sarepta Therapeutics, Inc. | $2.06B | Mid cap | +7.69% |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +28.14% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $2.03B | Mid cap | −13.45% |
| CMPS | COMPASS Pathways plc | $2.02B | Mid cap | +209.53% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +79.12% |
| KLRS | Kalaris Therapeutics, Inc. | $99.98M | Micro cap | +32.47% |
| 4BB.L | 4basebio PLC | $99.96M | Micro cap | −46.89% |
| CGTX | Cognition Therapeutics, Inc. | $99.85M | Micro cap | −65.69% |
| PARK | Park Dental Partners, Inc. | $99.15M | Micro cap | +103.41% |
| ABNX.PA | ABIONYX Pharma SA | $98.59M | Micro cap | −31.34% |
| 88Q.DE | 4basebio PLC | $96.59M | Micro cap | −45.69% |
| NANOFH.HE | Nanoform Finland Oyj | $95.78M | Micro cap | +15.66% |
| ILA.AX | Island Pharmaceuticals Limited | $95.70M | Micro cap | +109.30% |
| FBIO | Fortress Biotech, Inc. | $94.38M | Micro cap | +20.09% |
| PLYX | Polaryx Therapeutics, Inc. | $94.21M | Micro cap | −94.03% |
| 004080.KS | Shinhung Co., Ltd | $94.21M | Micro cap | +2.54% |
| ATRA | Atara Biotherapeutics, Inc. | $94.15M | Micro cap | −24.05% |
| ADOC.PA | Adocia SA | $93.77M | Micro cap | −54.33% |
| NANOFS.ST | Nanoform Finland Oyj | $93.63M | Micro cap | +19.56% |
| ALDX | Aldeyra Therapeutics, Inc. | $93.51M | Micro cap | −73.33% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +52.94% |
| BIOPOR.CO | BioPorto A/S | $93.40M | Micro cap | −3.13% |
| ECOR | electroCore, Inc. | $93.31M | Micro cap | +86.49% |
| 4579.T | RaQualia Pharma Inc. | $93.23M | Micro cap | +3.46% |
| ALC.AX | Alcidion Group Limited | $92.65M | Micro cap | −5.00% |
| PAR.AX | Paradigm Biopharmaceuticals Limited | $92.46M | Micro cap | −24.56% |
| HYPR | Hyperfine, Inc. | $92.06M | Micro cap | −29.99% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | $91.93M | Micro cap | +15.88% |
| 214390.KS | Kyongbo Pharmaceutical Co., Ltd | $91.77M | Micro cap | +9.78% |
| VISTN.OL | Vistin Pharma ASA | $91.60M | Micro cap | −15.42% |
| 4978.T | ReproCELL Incorporated | $91.60M | Micro cap | −16.29% |
| 4350.T | Medical System Network Co., Ltd. | $91.16M | Micro cap | +7.57% |
| ICCC | ImmuCell Corporation | $91.00M | Micro cap | +64.26% |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $90.10M | Micro cap | −11.35% |
| EAH.L | ECO Animal Health Group plc | $89.77M | Micro cap | +34.69% |
| RLYB | Rallybio Corporation | $89.64M | Micro cap | +257.63% |
| 3417.T | Ohki Healthcare Holdings Co.,Ltd. | $89.57M | Micro cap | −21.40% |
| 7V0.DE | Novogenia AG | $89.54M | Micro cap | −25.00% |
| OSE.PA | OSE Immunotherapeutics SA | $88.75M | Micro cap | −47.94% |
| 194A.T | WOLVES HAND CO LTD | $88.72M | Micro cap | +102.92% |
| 6678.T | Techno Medica Co., Ltd. | $88.35M | Micro cap | +12.34% |
| CWEB.TO | Charlotte's Web Holdings, Inc. | $88.25M | Micro cap | +253.85% |
| 002390.KS | HANDOK Inc. | $87.90M | Micro cap | −19.05% |
| NANEXA.ST | Nanexa AB (publ) | $87.59M | Micro cap | +100.43% |
| EQL.ST | EQL Pharma AB (publ) | $87.58M | Micro cap | −67.01% |
| AALR3.SA | Alliança Saúde e Participações S.A. | $87.57M | Micro cap | −52.03% |
| CVRX | CVRx, Inc. | $87.12M | Micro cap | −56.75% |
| ATHE | Alterity Therapeutics Limited | $86.64M | Micro cap | −4.40% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | $86.56M | Micro cap | +78.27% |
| BB1.AX | BLINKLAB FPO [BB1] | $86.46M | Micro cap | +47.22% |
| 001360.KS | SAMSUNG PHARM. Co., LTD. | $86.44M | Micro cap | −21.26% |
| CREO.L | Creo Medical Group PLC | $85.82M | Micro cap | −1.90% |
| CING | Cingulate Inc. | $85.36M | Micro cap | +29.19% |
| 4574.T | Taiko Pharmaceutical Co.,Ltd. | $85.35M | Micro cap | −11.80% |
| GOSS | Gossamer Bio, Inc. | $85.01M | Micro cap | −92.93% |
| 7792.T | Colan Totte.Co.,Ltd. | $84.83M | Micro cap | +6.32% |
| MAIA | MAIA Biotechnology, Inc. | $84.56M | Micro cap | −15.76% |
| VRCA | Verrica Pharmaceuticals Inc. | $84.35M | Micro cap | −13.25% |
| DH | Definitive Healthcare Corp. | $84.34M | Micro cap | −80.44% |
| ACET | Adicet Bio, Inc. | $83.79M | Micro cap | −26.01% |
| RPID | Rapid Micro Biosystems, Inc. | $83.77M | Micro cap | −34.77% |
| CTOR | Citius Oncology, Inc. | $83.24M | Micro cap | −62.34% |
| GANX | Gain Therapeutics, Inc. | $83.14M | Micro cap | −2.69% |
| SERA | Sera Prognostics, Inc. | $82.45M | Micro cap | −26.41% |
| POLB.L | Poolbeg Pharma PLC | $82.41M | Micro cap | +164.62% |
| RCE.AX | Recce Pharmaceuticals Ltd | $82.40M | Micro cap | −10.71% |
| 002620.KS | Jeil Pharma Holdings Inc | $81.83M | Micro cap | −16.20% |
| HIGH.DE | Cantourage Group SE | $81.55M | Micro cap | +51.90% |
| HLS.TO | HLS Therapeutics Inc. | $81.35M | Micro cap | −30.48% |
| OKYO | OKYO Pharma Limited | $81.34M | Micro cap | −31.42% |
| OMDA.OL | Omda AS | $81.21M | Micro cap | −23.98% |
| OBI.L | Ondine Biomedical Inc. | $81.20M | Micro cap | −24.19% |
| INIFY.OL | INIFY Laboratories AB | $81.09M | Micro cap | +44.55% |
| NXTMH.HE | Nexstim Plc | $80.89M | Micro cap | −26.64% |
| ATH.AX | Alterity Therapeutics Limited | $80.50M | Micro cap | −14.17% |
| TELO | Telomir Pharmaceuticals, Inc. | $80.47M | Micro cap | −20.95% |
| AB.PA | AB Science S.A. | $80.25M | Micro cap | −38.62% |
| 4888.T | Stella Pharma Corporation | $80.24M | Micro cap | −11.75% |
| OM | Outset Medical, Inc. | $79.89M | Micro cap | −69.56% |
| ELTX | Elicio Therapeutics, Inc. | $78.32M | Micro cap | −71.29% |
| DICOT.ST | Dicot Pharma AB | $78.22M | Micro cap | −76.06% |
| 7775.T | Daiken Medical Co., Ltd. | $77.26M | Micro cap | −2.84% |
| MDG.WA | Medicalgorithmics S.A. | $76.94M | Micro cap | −20.30% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +320.55% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −34.00% |
| CRDF | Cardiff Oncology, Inc. | $76.56M | Micro cap | −54.65% |
| ANVS | Annovis Bio, Inc. | $75.84M | Micro cap | −24.26% |
| LONA | LeonaBio, Inc. | $75.47M | Micro cap | +95.25% |
| 7097.T | SAKURASAKU PLUS,Co.,Ltd. | $75.04M | Micro cap | −0.99% |
| NRXS | NeurAxis, Inc. | $74.84M | Micro cap | +146.28% |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −31.36% |
| MNOV | MediciNova, Inc. | $72.85M | Micro cap | +10.45% |
| MDXH | MDxHealth SA | $72.15M | Micro cap | −84.51% |
| KOO.L | Kooth plc | $72.00M | Micro cap | −7.59% |
| STX.L | Shield Therapeutics plc | $71.97M | Micro cap | −37.42% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +131.74% |
| 4596.T | Kubota Pharmaceutical Holdings Co., Ltd. | $71.23M | Micro cap | +35.29% |
| ALTHX.PA | THX Pharma Société Anonyme | $71.22M | Micro cap | +73.96% |
| SPRO | Spero Therapeutics, Inc. | $71.05M | Micro cap | −38.38% |
| 4875.T | MediciNova, Inc. | $71.04M | Micro cap | +11.17% |
| IBIO | iBio, Inc. | $71.04M | Micro cap | +76.54% |
| ZTEK | Zentek Ltd. | $70.91M | Micro cap | −17.65% |
| 7702.T | JMS Co.,Ltd. | $70.66M | Micro cap | +6.20% |
| XBIT | XBiotech Inc. | $70.43M | Micro cap | −33.62% |
| ZLNA.OL | Zelluna ASA | $70.31M | Micro cap | +56.57% |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% |
| EXOZ | eXoZymes, Inc. | $69.89M | Micro cap | −22.42% |
| RNTX | Rein Therapeutics Inc. | $69.01M | Micro cap | −27.27% |
| DRIO | DarioHealth Corp. | $68.89M | Micro cap | −26.92% |
| 9341.T | GENOVA, Inc. | $68.87M | Micro cap | +1.56% |
| NNOX | Nano-X Imaging Ltd. | $68.83M | Micro cap | −77.77% |
| CSBR | Champions Oncology, Inc. | $68.36M | Micro cap | −25.45% |
| ONCO.ST | Oncopeptides AB (publ) | $68.14M | Micro cap | −67.92% |
| RNXT | RenovoRx, Inc. | $67.24M | Micro cap | +61.08% |
| LDX.AX | Lumos Diagnostics Holdings Limited | $67.22M | Micro cap | −25.93% |
| HYFT | MindWalk Holdings Corp. | $67.19M | Micro cap | −46.04% |
| SER | Serina Therapeutics, Inc. | $66.80M | Micro cap | −47.29% |
| AVE.AX | Avecho Biotechnology Limited | $66.64M | Micro cap | +300.00% |
| BOLD | Boundless Bio, Inc. | $66.31M | Micro cap | +155.70% |
| GENT.OL | Gentian Diagnostics ASA | $65.68M | Micro cap | −30.41% |
| MAAT.PA | MaaT Pharma SA | $65.60M | Micro cap | −33.91% |
| 2934.T | J Frontier Co.,Ltd. | $65.60M | Micro cap | −2.11% |
| TLPH | Talphera, Inc. | $65.40M | Micro cap | +133.33% |
| LYTIX.OL | Lytix Biopharma ASA | $64.69M | Micro cap | −4.19% |
| LTP.AX | LTR PHARMA FPO [LTP] | $64.66M | Micro cap | −4.95% |
| AJ91.DE | DocCheck AG | $64.48M | Micro cap | −9.92% |
| HEALTH.HE | Nightingale Health Oyj | $64.18M | Micro cap | −57.24% |
| R0L.F | J Frontier Co.,Ltd. | $64.05M | Micro cap | −44.02% |
| 4570.T | Immuno-Biological Laboratories Co., Ltd. | $64.00M | Micro cap | +140.06% |
| ALGAE.PA | Fermentalg SA | $63.69M | Micro cap | −10.00% |
| 3079.T | DVx Inc. | $61.76M | Micro cap | −7.30% |
| IMA | ImageneBio, Inc. | $61.64M | Micro cap | −60.19% |
| SEZI.ST | Senzime AB (publ) | $61.48M | Micro cap | −39.98% |
| MYO | Myomo, Inc. | $60.60M | Micro cap | +36.61% |
| AHC.AX | Austco Healthcare Limited | $60.60M | Micro cap | −37.14% |
| DMVF3.SA | d1000 Varejo Farma Participações S.A. | $60.44M | Micro cap | +29.47% |
| INKT | MiNK Therapeutics, Inc. | $60.16M | Micro cap | −26.22% |
| HVO.L | hVIVO plc | $59.87M | Micro cap | −35.00% |
| 9265.T | Yamashita Health Care Holdings,Inc. | $59.83M | Micro cap | +24.40% |
| XLO | Xilio Therapeutics, Inc. | $59.55M | Micro cap | −5.63% |
| HRTX | Heron Therapeutics, Inc. | $59.27M | Micro cap | −77.04% |
| V3V.DE | FamiCord AG | $58.74M | Micro cap | −61.35% |
| DXR | Daxor Corporation | $58.53M | Micro cap | −11.60% |
| 7133.T | HYUGA PRIMARY CARE Co.,Ltd. | $57.90M | Micro cap | −0.72% |
| 4524.T | Morishita Jintan Co., Ltd. | $57.77M | Micro cap | +4.22% |
| 3446.T | JTEC Corporation | $57.54M | Micro cap | +32.62% |
| 7776.T | CellSeed Inc. | $57.40M | Micro cap | −47.39% |
| COCH | Envoy Medical, Inc. | $56.82M | Micro cap | −37.09% |
| 4896.T | K Pharma,Inc. | $56.45M | Micro cap | +14.56% |
| SCYX | SCYNEXIS, Inc. | $56.41M | Micro cap | +579.04% |
| 4564.T | OncoTherapy Science, Inc. | $56.36M | Micro cap | −25.00% |
| IMMP | Immutep Limited | $56.00M | Micro cap | −77.11% |
| 063160.KS | CKD Bio Corp. | $55.95M | Micro cap | −38.38% |
| ALTHE.PA | Theraclion SA | $55.29M | Micro cap | −22.30% |
| 7963.T | Koken Ltd. | $55.17M | Micro cap | +3.90% |
| ALSMA.PA | S.M.A.I.O S.A. | $54.96M | Micro cap | +14.29% |
| ALKLH.PA | Klea Holding SA | $54.74M | Micro cap | −32.00% |
| NTRB | Nutriband Inc. | $54.70M | Micro cap | −29.80% |
| 4571.T | Nano Holdings, Inc. | $54.57M | Micro cap | −31.79% |
| BVC.L | BATM Advanced Communications Ltd. | $54.53M | Micro cap | −21.90% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | $54.52M | Micro cap | +70.43% |
| GNTA | Genenta Science S.p.A. | $54.49M | Micro cap | −70.07% |
| 000230.KS | Ildong Holdings Co., Ltd. | $54.25M | Micro cap | −29.17% |
| ATX.AX | Amplia Therapeutics Limited | $54.23M | Micro cap | −14.71% |
| SRTS | Sensus Healthcare, Inc. | $54.16M | Micro cap | +3.46% |
| ATYR | aTyr Pharma, Inc. | $54.05M | Micro cap | −89.34% |
| IMM.AX | Immutep Limited | $54.01M | Micro cap | −79.18% |
| ALA.AX | Arovella Therapeutics Limited | $53.86M | Micro cap | −30.34% |
| EPIS-B.ST | Episurf Medical AB (publ) | $53.85M | Micro cap | +71.52% |
| 4572.T | Carna Biosciences, Inc. | $53.63M | Micro cap | +81.90% |
| MOB.ST | Moberg Pharma AB (publ) | $53.40M | Micro cap | +32.92% |
| FLUO.ST | FluoGuide A/S | $53.21M | Micro cap | −18.34% |
| TIL | Instil Bio, Inc. | $53.10M | Micro cap | −72.04% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | $52.93M | Micro cap | −46.25% |
| TELY.TO | TelyRx Holdings Inc. | $52.69M | Micro cap | −21.43% |
| HYPD | Hyperion DeFi, Inc. | $52.68M | Micro cap | −50.87% |
| BTMD | biote Corp. | $52.54M | Micro cap | −53.87% |
| MODU.HE | Modulight Oyj | $52.26M | Micro cap | −19.92% |
| MDAI | Spectral AI, Inc. | $51.82M | Micro cap | −23.33% |
| 9218.T | Mental Health Technologies Co.,Ltd. | $51.69M | Micro cap | −7.41% |
| 4597.T | Solasia Pharma K.K. | $51.40M | Micro cap | −18.92% |
| CANTA.ST | Cantargia AB (publ) | $51.16M | Micro cap | −27.38% |
| 002720.KS | Kukje Pharma Co., Ltd. | $51.04M | Micro cap | −29.09% |
| TCRX | TScan Therapeutics, Inc. | $50.80M | Micro cap | −58.43% |
| SVS.MI | Svas Biosana S.p.A. | $50.68M | Micro cap | +0.98% |
| PTX.AX | Prescient Therapeutics Limited | $50.63M | Micro cap | +63.41% |
| M3V.DE | MeVis Medical Solutions AG | $50.50M | Micro cap | −0.42% |
| 004720.KS | PharmGen Science, Inc. | $50.47M | Micro cap | −29.31% |
| HRTIS.HE | Herantis Pharma Oyj | $50.06M | Micro cap | −2.31% |
| AIFORIA.HE | Aiforia Technologies Oyj | $49.78M | Micro cap | −60.34% |
| IBO | Impact BioMedical Inc. | $49.62M | Micro cap | −24.12% |
| 8769.T | Advantage Risk Management Co., Ltd. | $49.53M | Micro cap | −12.77% |
| COIL.L | Coiled Therapeutics plc | $49.30M | Micro cap | −26.92% |
| ORX.ST | Orexo AB (publ) | $48.90M | Micro cap | −35.06% |
| 7096.T | StemCell Institute Inc. | $48.15M | Micro cap | −22.80% |
| NSRX | Nasus Pharma Ltd. | $48.01M | Micro cap | −49.75% |
| MLSS | Milestone Scientific Inc. | $47.87M | Micro cap | −10.10% |
| MCRB | Seres Therapeutics, Inc. | $47.81M | Micro cap | −74.79% |
| EDSA | Edesa Biotech, Inc. | $47.63M | Micro cap | +105.83% |
| POCI | Precision Optics Corporation, Inc. | $47.61M | Micro cap | −12.30% |
| SVE.WA | Synthaverse S.A. | $47.18M | Micro cap | −36.25% |
| 3628.T | Data Horizon Co.,Ltd. | $47.15M | Micro cap | +7.64% |
| 4890.T | Tsubota Laboratory Incorporated | $46.94M | Micro cap | −21.25% |
| PHX.AX | PharmX Technologies Limited | $46.91M | Micro cap | −17.39% |
| M7T.AX | Mach7 Technologies Limited | $46.78M | Micro cap | −13.85% |
| CYC.AX | Cyclopharm Limited | $46.72M | Micro cap | −48.30% |
| ALGS | Aligos Therapeutics, Inc. | $46.65M | Micro cap | −33.72% |
| 3671.T | Softmax Co., Ltd | $46.63M | Micro cap | −7.87% |
| BIOBV.HE | Biohit Oyj | $46.63M | Micro cap | −8.13% |
| QTI | QT Imaging Holdings, Inc. | $46.40M | Micro cap | −91.44% |
| GRCE | Grace Therapeutics, Inc. | $46.28M | Micro cap | −29.97% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | $46.19M | Micro cap | −39.08% |
| IMMU.ST | Mendus AB (publ) | $46.19M | Micro cap | −4.57% |
| MGX | Metagenomi Therapeutics, Inc. | $46.09M | Micro cap | −34.41% |
| 2370.T | MEDINET Co., Ltd. | $45.96M | Micro cap | −33.33% |
| FLNA | Filana Therapeutics, Inc. | $45.83M | Micro cap | −59.98% |
| AIAI.TO | NetraMark Holdings Inc. | $45.68M | Micro cap | −60.82% |
| CLBIO.ST | Corline Biomedical AB | $45.27M | Micro cap | +45.56% |
| ABLD.PA | ABL Diagnostics Société anonyme | $44.99M | Micro cap | −46.67% |
| OSSD.ST | OssDsign AB (publ) | $44.89M | Micro cap | −73.26% |
| IXHL | Incannex Healthcare Inc. | $44.87M | Micro cap | −81.59% |
| ENZY.ST | Enzymatica AB (publ) | $44.85M | Micro cap | −20.17% |
| 3386.T | Cosmo Bio Company,Limited | $44.68M | Micro cap | +7.72% |
| MREO | Mereo BioPharma Group plc | $44.39M | Micro cap | −84.20% |
| 6059.T | UCHIYAMA HOLDINGS Co.,Ltd. | $44.32M | Micro cap | +14.24% |
| ELUT | Elutia Inc. | $44.29M | Micro cap | −54.75% |
| MPAL.L | MedPal AI PLC | $44.20M | Micro cap | −40.00% |
| 9340.T | ASO International, Inc. | $44.19M | Micro cap | +0.18% |
| NEPH | Nephros, Inc. | $43.98M | Micro cap | 0.00% |
| CTE.AX | Cryosite Limited | $43.85M | Micro cap | +56.25% |
| ONCIN.OL | Oncoinvent ASA | $43.71M | Micro cap | +10.90% |
| TVGN | Tevogen Inc. | $43.63M | Micro cap | −85.43% |
| 3750.T | ADR Biomedical Holdings Inc. | $43.59M | Micro cap | −14.11% |
| 4880.T | CellSource Co., Ltd. | $43.15M | Micro cap | −42.78% |
| ALCOX.PA | Nicox S.A. | $43.02M | Micro cap | +2.70% |
| ALNOV.PA | Novacyt S.A. | $42.69M | Micro cap | +7.38% |
| 000220.KS | Yuyu Pharma, Inc. | $42.60M | Micro cap | −11.87% |
| PAVM | PAVmed Inc. | $42.54M | Micro cap | −63.21% |
| VVEO3.SA | CM Hospitalar S/A | $42.35M | Micro cap | −24.72% |
| NCYT.L | Novacyt S.A. | $42.07M | Micro cap | +7.81% |
| OPTOMED.HE | Optomed Oyj | $41.93M | Micro cap | −54.39% |
| SNWV | SANUWAVE Health, Inc. | $41.89M | Micro cap | −89.02% |
| NSPR | InspireMD, Inc. | $41.69M | Micro cap | −63.52% |
| PMED.MI | PiùMedical S.p.A. | $41.46M | Micro cap | −3.55% |
| BOT.AX | Botanix Pharmaceuticals Limited | $41.30M | Micro cap | −86.67% |
| MOC.WA | Molecure S.A. | $41.03M | Micro cap | −22.39% |
| SHG.AX | Singular Health Group Ltd | $41.01M | Micro cap | −46.15% |
| LGP.AX | Little Green Pharma Ltd | $40.46M | Micro cap | −43.33% |
| 4893.T | Noile-Immune Biotech Inc. | $40.36M | Micro cap | −16.38% |
| CRVO | CervoMed Inc. | $40.07M | Micro cap | −71.78% |
| MNTC.ST | Mentice AB (publ) | $40.01M | Micro cap | −6.59% |
| CNTX | Context Therapeutics Inc. | $40.00M | Micro cap | −50.73% |
| 206A.T | PRISM BioLab Co.,LTD | $39.48M | Micro cap | −5.56% |
| 002630.KS | ORIENT BIO Inc. | $39.42M | Micro cap | +49.67% |
| DCGO | DocGo Inc. | $39.10M | Micro cap | −75.60% |
| 7079.T | WDB coco Co., Ltd. | $39.00M | Micro cap | −3.52% |
| PKY.AX | Pathkey.AI Ltd | $38.82M | Micro cap | +77.27% |
| PETS | PetMed Express, Inc. | $38.81M | Micro cap | −43.35% |
| CPHI | China Pharma Holdings, Inc. | $38.68M | Micro cap | −35.78% |
| IVACC.ST | Intervacc AB (publ) | $38.50M | Micro cap | +4.78% |
| 7980.T | Shigematsu Works Co., Ltd. | $38.11M | Micro cap | +6.69% |
| SNT.AX | Syntara Limited | $38.09M | Micro cap | +1.89% |
| ORT-B.ST | Ortoma AB (publ) | $37.82M | Micro cap | −66.52% |
| BDMD | Baird Medical Investment Holdings Limited | $37.74M | Micro cap | −52.03% |
| MVP.AX | Medical Developments International Limited | $37.65M | Micro cap | −19.83% |
| NAVA.OL | Navamedic ASA | $37.60M | Micro cap | −32.27% |
| 7707.T | Precision System Science Co., Ltd. | $37.57M | Micro cap | +6.34% |
| 7681.T | LEOCLAN Co.,Ltd. | $37.16M | Micro cap | −10.99% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.